These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

379 related articles for article (PubMed ID: 28825867)

  • 1. Adjuvants for allergy immunotherapeutics.
    Gamazo C; D'Amelio C; Gastaminza G; Ferrer M; Irache JM
    Hum Vaccin Immunother; 2017 Oct; 13(10):2416-2427. PubMed ID: 28825867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunotherapy of Food Allergy: a Comprehensive Review.
    Wai CYY; Leung NYH; Leung PSC; Chu KH
    Clin Rev Allergy Immunol; 2019 Aug; 57(1):55-73. PubMed ID: 28929421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Adjuvants].
    Brehler R
    Hautarzt; 2017 Apr; 68(4):292-296. PubMed ID: 28130604
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CpG Adjuvant in Allergen-Specific Immunotherapy: Finding the Sweet Spot for the Induction of Immune Tolerance.
    Montamat G; Leonard C; Poli A; Klimek L; Ollert M
    Front Immunol; 2021; 12():590054. PubMed ID: 33708195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunotherapy for pet allergies.
    Virtanen T
    Hum Vaccin Immunother; 2018 Apr; 14(4):807-814. PubMed ID: 29182437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjuvants in Allergen-Specific Immunotherapy: Modulating and Enhancing the Immune Response.
    Zubeldia JM; Ferrer M; Dávila I; Justicia JL
    J Investig Allergol Clin Immunol; 2019; 29(2):103-111. PubMed ID: 30418155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allergen immunotherapy: an updated review of safety.
    James C; Bernstein DI
    Curr Opin Allergy Clin Immunol; 2017 Feb; 17(1):55-59. PubMed ID: 27906697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanoparticle based-immunotherapy against allergy.
    Gamazo C; Gastaminza G; Ferrer M; Sanz ML; Irache JM
    Immunotherapy; 2014; 6(7):885-97. PubMed ID: 25290419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Skin as a novel route for allergen-specific immunotherapy.
    Li W; Zhang Z; Tian R; Zhang K
    Curr Pharm Des; 2014; 20(6):886-91. PubMed ID: 23701565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunotheraphy in Allergic Diseases.
    Roger A; Basagana M; Teniente-Serra A; Depreux N; Jurgens Y; Padro C; Miquel S; Elduque C; Martinez-Caceres EM
    Curr Pharm Des; 2018; 24(11):1174-1194. PubMed ID: 29336248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical use of adjuvants in allergen-immunotherapy.
    Klimek L; Schmidt-Weber CB; Kramer MF; Skinner MA; Heath MD
    Expert Rev Clin Immunol; 2017 Jun; 13(6):599-610. PubMed ID: 28162007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA-based immunotherapeutics for the treatment of allergic disease.
    Horner AA; Van Uden JH; Zubeldia JM; Broide D; Raz E
    Immunol Rev; 2001 Feb; 179():102-18. PubMed ID: 11292014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanoparticle-allergen complexes for allergen immunotherapy.
    Di Felice G; Colombo P
    Int J Nanomedicine; 2017; 12():4493-4504. PubMed ID: 28684909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting IgE to facilitate oral immunotherapy for food allergy: a potential new role for anti-IgE therapy?
    Umetsu DT
    Expert Rev Clin Immunol; 2014 Sep; 10(9):1125-8. PubMed ID: 25119422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allergen immunotherapy.
    Huggins JL; Looney RJ
    Am Fam Physician; 2004 Aug; 70(4):689-96. PubMed ID: 15338781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emerging Approaches to Food Desensitization in Children.
    Hamad A; Burks WA
    Curr Allergy Asthma Rep; 2017 May; 17(5):32. PubMed ID: 28429307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modified allergens and their potential to treat allergic disease.
    Jongejan L; van Ree R
    Curr Allergy Asthma Rep; 2014 Dec; 14(12):478. PubMed ID: 25269402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Engineering, characterization and in vitro efficacy of the major peanut allergens for use in immunotherapy.
    Bannon GA; Cockrell G; Connaughton C; West CM; Helm R; Stanley JS; King N; Rabjohn P; Sampson HA; Burks AW
    Int Arch Allergy Immunol; 2001; 124(1-3):70-2. PubMed ID: 11306930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allergen-specific immunotherapy.
    Niederberger V
    Immunol Lett; 2009 Feb; 122(2):131-3. PubMed ID: 19100771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential of nanoparticles for allergen-specific immunotherapy - use of silica nanoparticles as vaccination platform.
    Scheiblhofer S; Machado Y; Feinle A; Thalhamer J; Hüsing N; Weiss R
    Expert Opin Drug Deliv; 2016 Dec; 13(12):1777-1788. PubMed ID: 27321476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.